Amicus Therapeutics earned Zacks Rank #2 following promising estimate revisions.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amicus Therapeutics earned Zacks Rank #2 following promising estimate revisions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amicus Therapeutics
company in Cranbury, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksEarnings Estimates Moving Higher for Amicus Therapeutics (FOLD): Time to Buy? Amicus Therapeutics (FOLD) could be a solid choice for investors given the company's remarkably improving earnings outloo